Australia's largest stock trading and investment forum Australia's #1 stock forum

LVT

0.00%

0.6¢ livetiles limited

something is a foot, page-26

First 26 Last

Share
Profile

Follow
TMoney123

51 Posts.

54

09/10/21

18:44

Post #: 56683933
Share

Originally posted by JPjpJPjpJP: ↑

The vast majority of brokers don’t even bother to cover LVT. It’s not worth their time. Let’s look at the ones that do.

-Wilson’s does/did as their were LVTs corporate broker. Wilson had strong buy reco.
—Then Wilson’s was dropped as corporate broker for Citi. Citi initiated with a buy and Wilson’s flipped to sell.
-Citi still do their corp work (cap raises etc), but they now have a hold rating (ie. the bottom 30% of stocks they cover).
-Oppenheimer didn’t cover LVT until they were paid to help promote LVT in the US, and they initiated with a buy rating and 50c target price which hasn’t been updated for 18mo (since the last cheque from LVT was received).
-MST do partnership based coverage. Reading their reports, it’s probably safe to assume it’s paid promotion, as has been discussed on LVT boards numerous times over the past few years.

So to answer you question about LVT, the following reasons are likely related to a buy rating.
1) Analyst legitimately believes the stocks is going up
2) Corporate relationship where that broker is paid millions by the company in question to conduct all its capital markets activity.
3) Some other paid partnership.

1) is by far, far the most common, and based on the last 13 years of bull market run, buy ratings on good companies with 12mo target prices 5-20% above last will have largely been the right calls. Evans and Partners have a buy on LVT and haven’t been paid for any corporate activity to the best of my knowledge.

Analysts SHOULD work entirely independently from anything to do with IBCM activity… Buuut don’t forget about the influence of money in how the game works. If you were a company, would you ask a broker to do a cap raise for yourself if it had a sell recommendation on your business?

4 of the 5 brokers with historical buy recommendations will have been paid millions by LVT for their capital markets work.

Good luck, I honestly want LVT to succeed and I want to buy back in for the ride.

On a personal basis, you have a lot to learn about how the financial markets work and you won’t learn if you’re closed off to thoughts or suggestions contrary to what you believe.

Expand

Originally posted by Eloi75: ↑

So you have just confirmed and agreed with me that no broker will give a strong buy on a stock that they believe is shit.

Well thanks for wasting my time. LMAO

For a guy who claims to work from a broking firm you do like to talk shit and waste peoples time when it comes to finance.

Expand

I’ll just add to this that if anyone actually listens to these broker ratings, then it’s a sure fire way to lose money. The vast majority of all ratings are absolutely either garbage, manipulation or paid marketing.

No offence JP and not singling you out, I work in the finance industry also and I very much question the ethics of so-called broker/research houses.

LVT Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

There are more pages in this discussion • 75 more messages in this thread...

First 26 Last

Add LVT (ASX) to my watchlist

(20min delay)
Last 0.6¢		Change 0.000(0.00%)		Mkt cap ! $6.474M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

something is a foot, page-26

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Featured News

Featured News

something is a foot, page-26

Top Stories

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Featured News

Featured News